Cargando…

Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy

Viral polymerase is an essential enzyme for the amplification of the viral genome and is one of the major targets of antiviral therapies. However, a serious concern to be solved in hepatitis B virus (HBV) infection is the difficulty of eliminating covalently closed circular (ccc) DNA. More recently,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohsaki, Eriko, Suwanmanee, Yadarat, Ueda, Keiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473100/ https://www.ncbi.nlm.nih.gov/pubmed/34578273 http://dx.doi.org/10.3390/v13091691

Ejemplares similares

ATP5B Is an Essential Factor for Hepatitis B Virus Entry
por: Ueda, Keiji, et al.
Publicado: (2022)

Analysis of the Physicochemical Properties, Replication and Pathophysiology of a Massively Glycosylated Hepatitis B Virus HBsAg Escape Mutant
por: Hossain, Md. Golzar, et al.
Publicado: (2021)

Screening and Evaluation of Novel Compounds against Hepatitis B Virus Polymerase Using Highly Purified Reverse Transcriptase Domain
por: Ohsaki, Eriko, et al.
Publicado: (2020)

Establishment of a system for finding inhibitors of ε RNA binding with the HBV polymerase
por: Liu, Xiao‐Quan, et al.
Publicado: (2020)

Impact of the Interaction of Hepatitis B Virus with Mitochondria and Associated Proteins
por: Hossain, Md. Golzar, et al.
Publicado: (2020)

Identification of the Interaction between Minichromosome Maintenance Proteins and the Core Protein of Hepatitis B Virus
por: Du, Kaili, et al.
Publicado: (2023)

Kaposi’s Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency
por: Ohsaki, Eriko, et al.
Publicado: (2012)

Interplay Between KSHV and the Host DNA Damage Response
por: Ohsaki, Eriko, et al.
Publicado: (2020)

Characterization of Kaposi's Sarcoma-Associated Herpesvirus-Related Lymphomas by DNA Microarray Analysis
por: Ueda, Keiji, et al.
Publicado: (2011)

Importance of Promyelocytic Leukema Protein (PML) for Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication
por: Hossain, Md. Golzar, et al.
Publicado: (2018)

Inhibition of LINE-1 Retrotransposition by Capsaicin
por: Nishikawa, Yuki, et al.
Publicado: (2018)

Complete Genome Sequence of a Precore-Defective Hepatitis B Virus Genotype D2 Strain Isolated in Bangladesh
por: Hossain, Md Golzar, et al.
Publicado: (2020)

Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B
por: Shakado, Satoshi, et al.
Publicado: (2008)

Combination Therapy for Chronic Hepatitis B: Current Indications
por: Paul, Navin, et al.
Publicado: (2011)

Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
por: Boussios, Stergios, et al.
Publicado: (2019)

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives
por: Su, Tung-Hung, et al.
Publicado: (2017)

Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
por: Powdrill, Megan H., et al.
Publicado: (2010)

Entecavir-based combination therapies for chronic hepatitis B: A meta-analysis
por: Luo, Aoran, et al.
Publicado: (2018)

The Therapeutic Approaches for Hepatitis C Virus: Protease Inhibitors and Polymerase Inhibitors
por: Kwo, Paul Y., et al.
Publicado: (2011)

Challenges in the Application of Glyco-Technology to Hepatitis B Virus Therapy and Diagnosis
por: Ouchida, Tsunenori, et al.
Publicado: (2021)

Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy
por: Ström, Cecilia E., et al.
Publicado: (2012)

Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C
por: Costantino, Angela, et al.
Publicado: (2015)

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
por: Nishikawa, Hiroki, et al.
Publicado: (2012)

A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI‐2173 in patients with chronic hepatitis B virus infection
por: Squires, Katherine E., et al.
Publicado: (2022)

Characterization of thiobarbituric acid derivatives as inhibitors of hepatitis C virus NS5B polymerase
por: Lee, Jong-Ho, et al.
Publicado: (2011)

Hepatitis B Viral Surface Mutations in Patients with Adefovir Resistant Chronic Hepatitis B with A181T/V Polymerase Mutations
por: Kim, Jeong Han, et al.
Publicado: (2010)

Novel therapeutic strategies for chronic hepatitis B
por: Phillips, Sandra, et al.
Publicado: (2022)

Potential clinical application of RNAi‐based therapeutic strategies for treatment of chronic hepatitis B
por: Zhaori, Getu
Publicado: (2018)

Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking
por: Wei, Yu, et al.
Publicado: (2016)

Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
por: Eltahla, Auda A., et al.
Publicado: (2015)

RNA interference as a novel treatment strategy for chronic hepatitis B infection
por: Hui, Rex Wan-Hin, et al.
Publicado: (2022)

Hepatitis B: treatment strategies and resistance
por: Soriano, Vincent
Publicado: (2010)

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
por: Yim, Hyung Joon
Publicado: (2016)

Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
por: Jang, Byoung Kuk
Publicado: (2020)

A Traditional Chinese Medicine, Maoto, Suppresses Hepatitis B Virus Production
por: Rahman, Md. Arifur, et al.
Publicado: (2021)

Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus
por: Menne, Stephan, et al.
Publicado: (2020)

New Pyrazolobenzothiazine Derivatives as Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors
por: Manfroni, Giuseppe, et al.
Publicado: (2014)

Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity
por: Hossain, Md. Golzar, et al.
Publicado: (2017)

Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021)

Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System
por: Biomy, Reda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a0jrv5907j73vhs3mrnci6c9e2